Figure 3
Figure 3. Expression of activating and inhibitory receptors on sHLA-G–treated NK cells. Cytofluorimetric analysis of the expression of activatory and inhibitory receptors on purified total NK cells, gating on CD56bright or CD56dim NK cells on the basis of CD56 expression. Expression of NK-cell receptors was evaluated on PB CD56bright (A) and CD56dim NK cells (B) or tonsil CD56bright (C) and CD56dim NK cells (D), either untreated (black bars) or treated with sHLA-G (white bars). Data are expressed as MRFI. Means of 5 different experiments ± SD are shown. Asterisks indicate significant differences. The insets in panels A through D show representative stainings of NK cells, ctr, or treated with sHLA-G, with anti-NKG2A and anti-CD94 mAbs, respectively. Black profiles indicate staining with specific mAbs, whereas gray profiles indicate staining with irrelevant isotype-matched mAb.

Expression of activating and inhibitory receptors on sHLA-G–treated NK cells. Cytofluorimetric analysis of the expression of activatory and inhibitory receptors on purified total NK cells, gating on CD56bright or CD56dim NK cells on the basis of CD56 expression. Expression of NK-cell receptors was evaluated on PB CD56bright (A) and CD56dim NK cells (B) or tonsil CD56bright (C) and CD56dim NK cells (D), either untreated (black bars) or treated with sHLA-G (white bars). Data are expressed as MRFI. Means of 5 different experiments ± SD are shown. Asterisks indicate significant differences. The insets in panels A through D show representative stainings of NK cells, ctr, or treated with sHLA-G, with anti-NKG2A and anti-CD94 mAbs, respectively. Black profiles indicate staining with specific mAbs, whereas gray profiles indicate staining with irrelevant isotype-matched mAb.

Close Modal

or Create an Account

Close Modal
Close Modal